Revolutionize Cancer Treatment: Advanced NK and γδ T Cell Therapy Strategies

Discover how cutting-edge cell therapy is transforming outcomes for acute myeloid leukemia patients

Are you struggling with high relapse rates in your stem cell transplant programs? Current haploidentical transplant approaches face a critical challenge: while donor T cells effectively fight leukemia, they also trigger dangerous graft-versus-host disease, leading to unacceptable patient mortality.

There's a better way.

Join our exclusive webinar to explore a breakthrough therapeutic strategy that harnesses the power of natural killer (NK) and γδ T cells to eliminate leukemia while avoiding life-threatening complications. Our innovative approach has demonstrated that enriched NK and γδ T cell grafts deliver superior anti-tumor activity without the devastating side effects of traditional methods.

What You'll Discover: 

Using advanced spectral flow cytometry analysis, we've identified the precise cellular mechanisms that make this approach so effective. Our magnetic depletion technique removes problematic αβ T and B cells while preserving and activating the therapeutic cell populations you need. The result? Enhanced CD137L/CD137 signaling, increased NKG2D expression, and dramatically improved tumor targeting.

The clinical implications are game-changing: Our strategy is projected to significantly reduce relapse rates while minimizing non-relapse mortality—addressing both major failure modes of current haplo-HSCT protocols.

Key learnings:

• Master next-generation cell therapy design – Learn how to optimize donor grafts for maximum anti-leukemia effect with minimal toxicity
• Leverage NK and γδ T cells therapeutically – Understand why these cell populations outperform traditional approaches in preventing relapse and GvHD
• Apply translational research models – Discover how our bidirectional mouse haplo-HSCT platform accelerates clinical development
• Implement spectral flow cytometry – Gain practical insights into using advanced phenotyping to predict and monitor therapeutic outcomes

Who should attend:

This webinar is essential for professionals driving innovation in cell therapy and transplant medicine:

• Principal Investigators & Lab Directors seeking competitive advantages in immunotherapy research
• Clinical Scientists & Translational Researchers developing next-generation cancer treatments
• Immunologists & Cell Therapy Specialists in pharmaceutical, biotech, and academic settings
• Research Scientists & Postdocs working on hematologic malignancies or transplant immunology
• Lab Managers & Technical Leaders implementing advanced flow cytometry platforms

Transform Your Approach to Transplant Therapy

Don't miss this opportunity to gain actionable insights that could reshape your research strategy and improve patient outcomes. Whether you're optimizing existing protocols or developing new cell therapy products, this webinar delivers the scientific depth and practical applications you need to stay ahead.

Register Today 

Advance your expertise in immune cell therapy and position yourself at the forefront of cancer treatment innovation.